IPN, Delhi, India. Open 10-6pm

+91 9891296838 / 9811747774

Indian Pharma Network (IPN)

Medicines For Laryngeal Cancer Treatment

IPN, New Delhi can facilitate laryngeal cancer patient to “import of  Medicines For laryngeal Cancer Treatment” for personal use under “patient name basis” treatment in India. For this applicant is required to make an request application with required document. IPN, New Delhi will do the necessary process to obtain permission from Drugs Controller General (India) to import.

Laryngeal Cancer Treatment

The larynx, also known as the voice box, is a part of the respiratory system located in the neck, between the pharynx and the trachea. It contains the vocal cords, which play an important role in producing sound and enabling speech.

Cancers of the larynx are relatively common, particularly in individuals who smoke or use tobacco products. Treatment for laryngeal cancer may involve surgery, radiation therapy, chemotherapy, or a combination of these treatments, depending on the stage and location of the cancer, as well as the individual patient’s overall health and medical history.

The treatment of laryngeal cancer depends on the stage and location of the cancer, as well as the patient’s overall health and medical history. Surgery, radiation therapy, chemotherapy, and targeted therapy are all potential treatment options for laryngeal cancer. Medications used to treat laryngeal cancer may include:

Get Access to FDA Un approved Medicines in India,
For Laryngeal Cancer Treatment

Chemotherapy may be used to treat laryngeal cancer, either alone or in combination with other treatments such as surgery or radiation therapy. The specific chemotherapy drugs used may vary depending on the stage and location of the cancer, as well as the individual patient’s overall health and medical history.

Some commonly used chemotherapy drugs for laryngeal cancer include:

  • Cisplatin:
    This is a platinum-based chemotherapy drug that is often used in combination with radiation therapy to treat laryngeal cancer. Cisplatin works by interfering with the DNA in cancer cells, which can prevent them from growing and dividing.
  • Carboplatin:
    This is another platinum-based chemotherapy drug that may be used to treat laryngeal cancer, particularly in cases where cisplatin is not an appropriate option due to side effects or other factors.
  • 5-fluorouracil:
    This is a type of chemotherapy drug known as a pyrimidine analog, which works by interfering with the metabolism of cancer cells. 5-fluorouracil may be used alone or in combination with other chemotherapy drugs or radiation therapy to treat laryngeal cancer.
  • Docetaxel:
    This is a chemotherapy drug known as a taxane, which works by interfering with the ability of cancer cells to divide and grow. Docetaxel may be used in combination with other chemotherapy drugs to treat laryngeal cancer.

Targeted therapy medicines for larynx cancer treatment are designed to specifically target certain molecules or proteins that are involved in the growth and spread of cancer cells. Unlike chemotherapy, which can affect both cancerous and healthy cells, targeted therapies aim to attack cancer cells while sparing healthy cells.

Here are some examples of targeted therapy medicines used in the treatment of larynx cancer:

  1. Cetuximab:
    This is an antibody that targets the epidermal growth factor receptor (EGFR) on the surface of cancer cells. By blocking EGFR, cetuximab can slow down or stop the growth and spread of cancer cells. Cetuximab is often used in combination with radiation therapy to treat larynx cancer.

  2. Pembrolizumab:
    This is an immune checkpoint inhibitor that targets the programmed death-1 (PD-1) protein on immune cells. By blocking PD-1, pembrolizumab can help the immune system recognize and attack cancer cells. Pembrolizumab may be used alone or in combination with chemotherapy to treat larynx cancer.

  3. Erlotinib:
    This is a small molecule inhibitor that targets the EGFR protein inside cancer cells. By blocking EGFR, erlotinib can slow down or stop the growth and spread of cancer cells. Erlotinib is typically used in patients with advanced larynx cancer who have already received chemotherapy.

It is important to note that targeted therapy medicines may not be suitable for all patients with larynx cancer. Treatment options should be discussed with a healthcare provider who can determine the best course of action based on the patient’s individual case.

Immunotherapy medicines have emerged as an important class of drugs for the treatment of various types of cancer, including larynx cancer. These drugs work by enhancing the ability of the patient’s immune system to recognize and attack cancer cells. Here are some examples of immunotherapy medicines used in the treatment of larynx cancer:

  1. Pembrolizumab:
    This is an immune checkpoint inhibitor that targets the programmed death-1 (PD-1) protein on immune cells. By blocking PD-1, pembrolizumab can help the immune system recognize and attack cancer cells. Pembrolizumab may be used alone or in combination with chemotherapy to treat larynx cancer.

  2. Nivolumab:
    This is another immune checkpoint inhibitor that targets the PD-1 protein. Nivolumab may be used alone or in combination with other drugs to treat larynx cancer that has spread or come back after previous treatment.

  3. Durvalumab:
    This is an immune checkpoint inhibitor that targets the programmed death ligand-1 (PD-L1) protein on cancer cells. By blocking PD-L1, durvalumab can prevent cancer cells from evading the immune system. Durvalumab may be used alone or in combination with chemotherapy to treat larynx cancer.

  4. Atezolizumab:
    This is an immune checkpoint inhibitor that targets the PD-L1 protein. Atezolizumab may be used alone or in combination with chemotherapy to treat larynx cancer that has spread or come back after previous treatment.

It is important to note that immunotherapy medicines may not be suitable for all patients with larynx cancer. Treatment options should be discussed with a healthcare provider who can determine the best course of action based on the patient’s individual case. Additionally, these drugs can have side effects that should be monitored and managed by a healthcare professional.

Steroids may be used to help reduce inflammation and swelling caused by cancer or cancer treatment.

It’s important to note that the specific medications used to treat laryngeal cancer may vary depending on the individual patient’s specific situation, and that treatment decisions should be made in consultation with a healthcare professional.

Legitimate Healthcare Consultant and Facilitator In Delhi

If you have a question relating to anti-cancer medicines approved for treatment of Leukemia, a problem which you do not know how to resolve it, or concrete inquiry – we are here for you. We will answer you via email urgent@indianpharmanetwork.co.in  as soon as possible. If you prefer to be contacted by phone, please leave your phone number. Or text your message in WhatsApp Number +91 9891296838 / 9811747774.

Disclaimer

Please note that this article serves purely informational purposes, and Indian Pharma Network (“IPN, Delhi”) bears no responsibility for the opinions, advice, or information conveyed by the author, reviewer, or originator. It is important to note that this article should not be considered a substitute for medical advice, diagnosis, or treatment. Always seek guidance from your trusted physician or qualified healthcare professional to assess your medical situation. A qualified doctor has reviewed the aforementioned article, and IPN, Delhi disclaims any liability for any information or services rendered by third parties.

Keywords

Categories: Drugs for Multiple myeloma, Drugs for Leukemia, Drugs for Lymphoma, Drugs for Skin Cancer, Drugs for Myelofibrosis, Drugs for Soft Tissue Sarcoma, Drugs for Bone Marrow, Drugs for Anemia, Drugs for Blood Disorders.

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Legitimate Healthcare Consultant and Facilitator

If you have a question relating to anti-cancer medicines approved for treatment of Pancreatic Cancer, a problem which you do not know how to resolve it, or concrete inquiry – we are here for you. We will answer you via email urgent@indianpharmanetwork.co.in  as soon as possible. If you prefer to be contacted by phone, please leave your phone number. Or text your message in WhatsApp Number +91 9891296838 / 9811747774.

Shipped Anti-Cancer Drugs.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India.Helps you to access FDA approved Leukemia Cancer medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Anti Cancer Medicines in Mumbai, Delhi, Kolkata, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, and Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and Vadodara.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa

Indian Pharma Network
60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398